Popular Articles From: InterMune Reports Memorandum of Understanding in Connection with Consolidated Delaware Action to Hyperion Therapeutics Announces EMA Acceptance for Review of Marketing Authorization Application for RAVICTI(R)


Interactive Intelligence Group Inc. (Nasdaq:ININ), a global provider of software and services designed to improve the customer experience, is hosting a free Web event titled “ How Moving Your Contact Center to the Cloud Eliminates Risk: A New Way of Evaluating Cloud TCO .” Already attracting more than 500 registrants, this 90-minute webcast will be held Tuesday, Sept.
Sign-up for Interactive Intelligence to Host “How Moving Your Contact Center to the Cloud Eliminates Risk” Industry Web Event investment picks
LITTLE RIVER, S.C., June 25, 2014 (GLOBE NEWSWIRE) -- Integrated Environmental Technologies, Ltd.
Sign-up for Integrated Environmental Technologies, Ltd. Announces the Publication of Excelyte(TM) Test Results by Independent Hospital System investment picks
http://media.marketwire.com/attachments/200909/442969_inlogo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1145026&ProfileId=051205&sourceType=1 BILLERICA, MA --
Sign-up for Insulet Corporation Appoints Patrick J. Sullivan as President and Chief Executive Officer investment picks
InSite Vision Incorporated (OTCBB:INSV) today reported financial results for the quarter ended June 30, 2014.
Sign-up for InSite Vision Reports Second Quarter 2014 Financial Results investment picks
Insignia Systems, Inc. (Nasdaq:ISIG) (“Insignia” or “the Company”) today announced that it has secured continued access in all retailers that it had previously served under the Company’s Retail Access and Distribution Agreement with Valassis In-Store Solutions (“Valassis”). As previously announced, the agreement between Insignia and Valassis terminated effective August 11, 2014.
Sign-up for Insignia Systems, Inc. Retains Access in All Retailers Previously Available under Its Agreement with Valassis investment picks
ATHLONE, Ireland, July 30, 2014 (GLOBE NEWSWIRE) -- Innocoll AG (Nasdaq:INNL) (the "Company"), a global, commercial-stage, specialty pharmaceutical company that develops and manufactures a range of pharmaceutical products and medical devices using its proprietary collagen-based technologies, today announced the closing of its public offering of 6,500,000 American Depositary Shares ("ADSs"), each representing 1/13.25 ordinary shares, at a public offering price of $9.00 per ADS.
Sign-up for Innocoll AG Announces Closing of Initial Public Offering investment picks
Inland Real Estate Corporation (NYSE: IRC) today announced that it paid a cash distribution of $0.0475 per share on the outstanding shares of its common stock to common stockholders of record at the close of business on September 2, 2014.
Sign-up for Inland Real Estate Corporation Pays September and Declares October Cash Distribution to Common Stockholders investment picks
http://media.marketwire.com/attachments/201408/78363_ing.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1138488&ProfileId=051205&sourceType=1 ATLANTA, GA --
Sign-up for Ingenico Group, FreedomPay and ScanSource Consortium Power the First PCI-Certified P2PE and EMV Payment Solution in North America investment picks
Nuance Communications, Inc. (NASDAQ: NUAN) today announced that ING Netherlands has turned to Nuance’s voice and artificial intelligence (AI) technologies to power Inge, the new voice feature of ING Netherlands’ mobile banking app .
Sign-up for ING Introduces a Voice-Controlled Mobile Banking App Powered by Nuance investment picks
SAN DIEGO , Sept.
Sign-up for InfoSonics Reveals Its First LTE Smartphone: the verykool® SL5000 'Quantum' investment picks
Infoblox Inc. (NYSE:BLOX), the network control company, today announced that Infoblox IPv6 evangelist Tom Coffeen will give the keynote speech at the 7th annual North American IPv6 Technology Summit on Sept.
Sign-up for Infoblox Evangelist to Give Keynote Speech at 7th Annual North American IPv6 Technology Summit investment picks
Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) will be participating in the BMO Capital Markets 3 rd Annual Biotech Corporate Access Day on July 29, 2014.
Sign-up for Infinity to Participate in the BMO Capital Markets 3RD Annual Biotech Corporate Access Day investment picks
Industrial Alliance wins six awards from the Insurance & Financial Communicators Association (IFCA) Canada NewsWire QUEBEC CITY , July 17, 2014 /CNW Telbec/ - Industrial Alliance's Group Savings and Retirement sector was recognized for the excellence of its achievements in communications and marketing, receiving six awards from the Insurance & Financial Communicators Association (IFCA), an international association specializing in the insurance and financial services industry.
Sign-up for Industrial Alliance wins six awards from the Insurance & Financial Communicators Association (IFCA) investment picks
ATLANTA, July 31, 2014 (GLOBE NEWSWIRE) -- Supply Chain Commerce Solutions Provider Manhattan Associates, Inc. (Nasdaq:MANH) announced today that it has been named a leader in Forrester Research Inc.'s "The Forrester Wave™: Omnichannel Order Management, Q3 2014" published on July 29, 2014.
Sign-up for Independent Research Firm Names Manhattan Associates a Leader in Omni-Channel Order Management Report investment picks
Incyte Corporation (Nasdaq: INCY) today reported 2014 second-quarter financial results, including revenue from Jakafi ® (ruxolitinib), which is approved by the U.S. Food & Drug Administration (FDA) for the treatment of patients with intermediate or high-risk myelofibrosis (MF). The Company highlighted its strong financial position, driven by growing Jakafi sales in the U.S. and Jakavi ® (ruxolitinib) royalties outside the U.S., as well as the submission of the ruxolitinib supplemental New Drug Application (sNDA) in the U.S. for patients with uncontrolled polycythemia vera (PV). The Company also discussed its expanding clinical pipeline, which includes pivotal as well as proof of concept studies, and the multiple data presentations for the Company’s product candidates that were made at the recent American Society of Clinical Oncology (ASCO) meeting.
Sign-up for Incyte Reports 2014 Second-Quarter Financial Results and Updates Shareholders on Key Clinical Programs investment picks
Imprivata® (NYSE: IMPR), a leading provider of authentication and access management solutions for the healthcare industry, today announced financial results for the second quarter of fiscal 2014.
Sign-up for Imprivata, Inc. Reports Second Quarter 2014 Financial Results investment picks
WILMINGTON, Mass.
Sign-up for Implant Sciences Responds to Levi & Korsinsky, LLP Press Release /Solicitation investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0961044001&sourceType=1 http://media3.marketwire.com/logos/20121102-iiinew.jpg VANCOUVER, BRITISH COLUMBIA --
Sign-up for Imperial Update on Tailings Storage Facility Breach at Mount Polley Mine investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0966234001&sourceType=1 http://media3.marketwire.com/logos/20121102-iiinew.jpg VANCOUVER, BRITISH COLUMBIA --
Sign-up for Imperial Completes $115 Million Non-Brokered Private Placement of Convertible Debentures investment picks
SEATTLE and SOUTH SAN FRANCISCO, Calif., July 29, 2014 (GLOBE NEWSWIRE) -- Immune Design (Nasdaq:IMDZ) announced today the closing of its initial public offering of 5,000,000 shares, at a public offering price of $12.00 per share, resulting in aggregate gross proceeds of $60.0 million, before underwriting discounts, commissions and expenses.
Sign-up for Immune Design Announces Closing of Initial Public Offering investment picks
Plantronics (NYSE:PLT), a pioneer in audio and wearable technology, today announced BackBeat PRO , wireless active noise-cancelling headphones with battery power to outlast your playlist.
Sign-up for Immerse Yourself in Uncompromising Audio with the New Plantronics BackBeat PRO Wireless Active Noise-Cancelling Headphones investment picks
WINDERMERE, Fla.
Sign-up for iMedicor Signs Relationship with Florence-Darlington Technical College investment picks
Idera Pharmaceuticals, Inc. (NASDAQ: IDRA), a clinical stage biopharmaceutical company developing nucleic acid therapeutics for rare diseases, today reported financial and operational results for the quarter ended June 30, 2014.
Sign-up for Idera Pharmaceuticals Reports Second Quarter 2014 Financial Results and Provides Corporate Update investment picks
http://media.marketwire.com/attachments/201311/207012_jpg_IPC_Logo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1143512&ProfileId=051205&sourceType=1 AUSTIN, TX --
Sign-up for Ideal Power Appoints Industry Veteran Ryan O'Keefe as Senior Vice President, Business Development investment picks
BOISE, Idaho , Sept.
Sign-up for IDACORP Increases Quarterly Common Stock Dividend 9.3 Percent investment picks
RALEIGH, N.C., Aug.
Sign-up for Icon Media Holdings, Inc. Opens MMJ-X.COM for Beta investment picks
Actua to Trade on the NASDAQ Under Ticker Symbol ACTA RADNOR, Pa., Sept.
Sign-up for ICG Changes Name to Actua, Reflecting Evolution to a Multi-Vertical Cloud Company investment picks
BRISBANE, Calif., June 25, 2014 (GLOBE NEWSWIRE) -- Hyperion Therapeutics, Inc. (Nasdaq:HPTX) today announced that the European Medicines Agency (EMA) has completed technical and content validation and accepted the filing of the Marketing Authorisation Application (MAA) for RAVICTI (glycerol phenylbutyrate) Oral Liquid for the treatment of urea cycle disorders (UCDs). Acceptance of the MAA confirms that the submission is complete so as to permit a substantive review by the Rapporteurs and the Committee for Medicinal Products for Human Use (CHMP). "We are very pleased to receive MAA acceptance for review of RAVICTI and anticipate a CHMP opinion in the third quarter of 2015," said Donald J.
Sign-up for Hyperion Therapeutics Announces EMA Acceptance for Review of Marketing Authorization Application for RAVICTI(R) investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Popular Articles From: InterMune Reports Memorandum of Understanding in Connection with Consolidated Delaware Action to Hyperion Therapeutics Announces EMA Acceptance for Review of Marketing Authorization Application for RAVICTI(R)
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices